-
Signature
-
/s/Lisa Stockard as Attorney-in-Fact
-
Issuer symbol
-
EFX
-
Transactions as of
-
24 May 2024
-
Net transactions value
-
-$244,361
-
Form type
-
4
-
Filing time
-
29 May 2024, 16:39:20 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EFX |
Common Stock |
Options Exercise |
$991,276 |
+5,178 |
+31% |
$191.44 |
22,062 |
24 May 2024 |
Direct |
F1, F2 |
| transaction |
EFX |
Common Stock |
Sale |
$56,747 |
-241 |
-1.1% |
$235.46 |
21,821 |
24 May 2024 |
Direct |
F1, F2, F3 |
| transaction |
EFX |
Common Stock |
Sale |
$77,148 |
-324 |
-1.5% |
$238.11 |
21,497 |
24 May 2024 |
Direct |
F1, F2, F4 |
| transaction |
EFX |
Common Stock |
Sale |
$114,271 |
-476 |
-2.2% |
$240.07 |
21,021 |
24 May 2024 |
Direct |
F1, F2, F5 |
| transaction |
EFX |
Common Stock |
Sale |
$220,577 |
-931 |
-4.4% |
$236.92 |
20,090 |
24 May 2024 |
Direct |
F1, F2, F6 |
| transaction |
EFX |
Common Stock |
Sale |
$766,894 |
-3,206 |
-16% |
$239.21 |
16,884 |
24 May 2024 |
Direct |
F1, F2, F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EFX |
Stock Option/Right to Buy |
Options Exercise |
$0 |
-5,178 |
-100% |
$0.000000* |
0 |
24 May 2024 |
Common Stock |
5,178 |
$191.44 |
Direct |
F1, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: